Table 2.
FICD-transduced cells perform in NOD∕SCID mice
| Patient no. | Human BM FICD-transduced cells |
Mice used | NOD∕SCID mice assay |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 0 |
Day 63 |
BM |
Spleen colonies | Liver colonies | |||||||
| Cell count | CD34+ % | Cell count | CD34+ % | Colonies | CFU-readout |
||||||
| Erythroid | Myeloid | GEMM | |||||||||
| 5. Cha | 2 × 105 | 5 | 2 × 104 | 20 | 1 | 185 | 3 BFU-E, 4 CFU-E | 176 | 2 | 71 (21 clusters) | 0 |
| 7. Cas | 2 × 105 | 1 | 3.05 × 105 | 18 | 2 | 0 | — | — | — | 0 | 0 |
| 9. OCT | 2 × 105 | 0.50 | 3.2 × 105 | 25 | 2 | 13 | — | 6 GM, 4 M, 3 G | — | 0 | 0 |
hCFU assay from NOD∕SCID mice BM samples, 14 weeks (over 3 months) after infusion of transduced cells primarily grown in LTC for 9 weeks; CD34+ percentages were measured before infusion. Human CFUs were obtained only with cells from the early diagnosed patient.